Joann D Lim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Education & Training
- The Ohio State UniversityPharmD, 1995
Publications & Presentations
PubMed
- Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer.Kato, S.,Jardim, D. L.,Johnson, F. M.,Subbiah, V.,Piha-Paul, S.,Tsimberidou, A. M.,Falchook, G. S.,Karp, D.,Zinner, R.,Wheler, J.,Janku, F.,Fu, S.,Lim, J.,Bean, S.,Ngu...> ;Invest New Drugs. 2017 Oct 20
- Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers.Sen, S.,Kato, S.,Agarwal, R.,Piha-Paul, S.,Hess, K.,Karp, D.,Janku, F.,Fu, S.,Naing, A.,Pant, S.,Falchook, G.,Tang, C.,Wu, X.,Ye, Y.,Tsimberidou, A.,Subbiah, V.,Kurzro...> ;Br. J. Cancer. 2018 Apr 27
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-2564Fax+1 713-563-4001- Is this information wrong?
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: